Naturally occurring disease
Spontaneous onset and progression, not engineered or induced, with the variation that trials meet in practice.
Translational evidence platform
Outcome-linked molecular data from real-world veterinary care.
Armidus collects consented clinical records, follow-up outcomes and biological samples from animals treated in partner veterinary clinics, then links them to molecular profiles. Pharma, biotech, CROs and academic groups can license the data or commission new cohorts.
Example record
Consented
Subject A-0142
Canine · [BREED] · [AGE]
- Clinic agreement
- Signed
- Owner consent
- Written
- Diagnosis
- [INDICATION]
- Samples
- Germline · tissue
- Molecular profile
- [ASSAY]
Outcome timeline
- Visit
- Day 7
- Day 30
- Outcome
Why animal data
Disease as it actually occurs, outside the lab.
Companion animals develop many of the same diseases as people, in the same homes, with intact immune systems. Their care records capture what induced models cannot.
Intact immune systems
Immunocompetent patients, relevant wherever host immunity shapes response, from oncology to inflammation.
Shared environments
Animals live alongside people and share many of the same exposures, diets and microbes.
Shorter timelines to outcome
Shorter lifespans mean disease course and outcomes can be observed in a fraction of the human timeframe.
How it works
From a routine visit to an analysis-ready dataset.
-
Care
Partner clinics use Armidus to guide owners through post-visit care.
-
Consent
The clinic signs a data-sharing agreement. Each owner gives written consent.
-
Collect
Structured clinical records, owner-reported follow-up and biological samples.
-
Profile
Samples are profiled and linked to each patient's longitudinal outcomes.
-
Deliver
De-identified datasets licensed to partners, or new cohorts built to spec.
What partners get
One patient, linked across every layer.
Every sample is tied to the same patient's clinical history and what happened after the visit, so molecular findings can be read against real outcomes.
Clinical records
Diagnoses, treatments, medications and clinician notes, structured at the point of care.
Post-visit outcomes
Adherence, symptoms, recovery and escalations, reported by owners between visits.
Biological samples
Germline and tissue samples, collected with consent during routine care.
Molecular profiles
[ASSAY TYPES, e.g. genomic, transcriptomic] linked to each patient record.
Applications
Where the data fits in your work.
Target discovery
Find and test candidate mechanisms against naturally occurring disease and its outcomes.
Translational evidence
Add real-world efficacy and response data to support go or no-go decisions.
Reference data for NAMs
Outcome-linked tissue and reference data for developers of new approach methodologies (NAMs).
AI model training
Multimodal, longitudinal data with documented consent and provenance.
Consent & governance
Every record is consented in writing.
Armidus uses clinic and patient data for research only with explicit written consent: a signed data-sharing agreement from the clinic and written consent from the owner. Clinics that do not sign an agreement keep full use of Armidus, and their data is never shared.
Read how Armidus handles data-
Two-level consentA clinic agreement and owner consent are both required before any record is shared.
-
De-identified deliveryOwner and clinic identifiers are removed before data reaches a partner.
-
Regional environmentsEach production country runs in its own dedicated cloud environment, with data encrypted at rest and in transit.
-
Documented provenanceConsent status and collection history travel with every record.
Are you a veterinary clinic?
Armidus helps clinics support owners after the visit. Learn more about the clinic product.
Contact us
Tell us what you are trying to answer.
Share the indication, species or question you are working on. We will tell you what existing data covers it, or how a new cohort could.